Delivery Order SPE2DR25D1106-SPE2DR26FJD2X
Award Date 12/11/25
Potential Completion Date 1/5/26
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Skyrizi 600 mg/10 mL vials with a ceiling value of $12,239.38. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $19,347.63 to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Skyrizi 600 mg/10 ml vials. The contract, which is firm fixed price and non-competitive set-aside, has an ultimate completion date of December 16, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Skyrizi 600 mg/10 mL vials with a ceiling value of $24,478.76 and firm fixed pricing. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $12,898.42 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 600 mg/10 ml vials on December 4, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 26, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a $49,557.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Skyrizi 150 mg/mL pen/mL pharmaceutical product. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order is scheduled for completion by December 9,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,119.69 for SKYRIZI 600 mg/10 mL vials on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order is not set-aside and represents a competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Skyrizi 600 mg/10 mL vials. This competitive, firm fixed-price delivery order carries a ceiling value of $73,436.28 with an ultimate completion date of October 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Skyrizi 150 mg/ml pen units. This firm fixed price delivery order, with an ultimate completion date of October 28, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body 2.4 mL pharmaceutical product. The contract is unset-aside and competitively awarded, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location and an ultimate completion date of December 1, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $19,347.63 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of SKYRIZI 600 mg/10 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military...